Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PAZOPANIB Cause Aspartate aminotransferase increased? 223 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 223 reports of Aspartate aminotransferase increased have been filed in association with PAZOPANIB (Pazopanib). This represents 1.1% of all adverse event reports for PAZOPANIB.

223
Reports of Aspartate aminotransferase increased with PAZOPANIB
1.1%
of all PAZOPANIB reports
39
Deaths
79
Hospitalizations

How Dangerous Is Aspartate aminotransferase increased From PAZOPANIB?

Of the 223 reports, 39 (17.5%) resulted in death, 79 (35.4%) required hospitalization, and 25 (11.2%) were considered life-threatening.

Is Aspartate aminotransferase increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PAZOPANIB. However, 223 reports have been filed with the FAERS database.

What Other Side Effects Does PAZOPANIB Cause?

Death (3,767) Diarrhoea (2,907) Fatigue (1,883) Nausea (1,879) Malignant neoplasm progression (1,471) Drug ineffective (1,135) Decreased appetite (1,116) Vomiting (1,072) Hypertension (1,004) Malaise (764)

What Other Drugs Cause Aspartate aminotransferase increased?

METHOTREXATE (1,600) RITUXIMAB (1,351) ADALIMUMAB (1,166) TOCILIZUMAB (975) ETANERCEPT (939) ACETAMINOPHEN (865) LEFLUNOMIDE (863) INFLIXIMAB (823) ABATACEPT (778) NIVOLUMAB (758)

Which PAZOPANIB Alternatives Have Lower Aspartate aminotransferase increased Risk?

PAZOPANIB vs PEANUT PAZOPANIB vs PEG INTERFERON PAZOPANIB vs PEG-INTERFERON ALFA 2A PAZOPANIB vs PEGASPARGASE PAZOPANIB vs PEGASYS

Related Pages

PAZOPANIB Full Profile All Aspartate aminotransferase increased Reports All Drugs Causing Aspartate aminotransferase increased PAZOPANIB Demographics